News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Music

These middle school kids might be the next big metal band

unlockingthetruth

These Brooklyn boys don't need junior high talent shows, they've just signed a million-dollar deal.

in Music

Def Leppard postpones Vegas shows to record new album

defleppard

The rockers are postponing plans to head to Sin City to record a new album.

in Entertainment

‘The Best Man’ set for ‘threequel’

bestman

The new film appears to pick up from news Howard's character drops at the end of the "The Best Man Holiday," which was released last November.